细支气管腺瘤2例报道
2 Cases Report of Bronchiolar Adenoma
DOI: 10.12677/ACM.2024.141136, PDF,    科研立项经费支持
作者: 刘天星:延安大学医学院,陕西 延安;李文生*:陕西省人民医院病理科,陕西 西安
关键词: 肺肿瘤细支气管腺瘤病理形态免疫组织化学Lung Tumors Bronchial Adenoma Pathological Morphology Immunohistochemistry
摘要: 细支气管腺瘤(bronchiolar adenoma, BA)是WHO (2021)胸部肿瘤中新定义的一种临床表现惰性的较为少见的实体肺肿瘤,且易与黏液腺癌相混淆,尤其在术中冰冻时。本文报道2例女性病例,分别发生于右肺下叶和左肺上叶,镜下表现为肿瘤组织呈腺样排列,主要由纤毛细胞、黏液细胞、立方细胞构成,基底细胞部分缺失。免疫表型:肿瘤细胞CK7、TTF-1、NapsinA均阳性,基底细胞p40、p63、CK5/6阳性(例2仅p63强弱不等),p53呈野生型表达,EGFR阳性,Ki-67阳性指数分别约1%和10%,例2 ALK (D5F3)阳性、PD-L1 (SP263) TPS值 < 1%。通过本文报道的2例BA的复习,了解其病理形态及免疫表型特征,避免误诊。
Abstract: Bronchiolar adenoma (BA) is a relatively rare solid lung tumor newly defined by WHO (2021) in the field of chest tumors, with inert clinical manifestations, and is easily confused with mucinous ade-nocarcinoma, especially during intraoperative freezing. This article reports two female cases, occur-ring, respectively in the right lower lobe and left upper lobe. Microscopically, the tumor tissue ap-pears as glandular arrangement, mainly composed of ciliated cells, mucus cells, and cuboid cells, with partial absence of basal cells. Immunophenotypes: tumor cells CK7, TTF-1, and NapsinA are all positive, while basal cells p40, p63, and CK5/6 are positive (case 2 only shows varying strength of p63). p53 is expressed in the wild-type, EGFR is positive, and Ki-67 positivity index is about 1% and 10%. ALK (D5F3) of Case 2 is positive, and PD-L1 (SP263) TPS value is less than 1%. By reviewing the two cases of BA reported in this article, we aim to understand their pathological morphology and immunophenotypic characteristics to avoid misdiagnosis.
文章引用:刘天星, 李文生. 细支气管腺瘤2例报道[J]. 临床医学进展, 2024, 14(1): 954-958. https://doi.org/10.12677/ACM.2024.141136

参考文献

[1] Ishikawa, Y. (2002) Ciliated Muconodular Papillary Tumor of the Peripheral Lung: Benign or Malignancy? Pathology and Clinical Medicine (Byori to Rinsho), 20, 964-965.
[2] Chang, J.C., Montecalvo, J., Borsu, L., et al. (2018) Bron-chiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors with Proposal for Revised Ter-minology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases. The American Journal of Surgical Pathology, 42, 1010-1026. [Google Scholar] [CrossRef
[3] Nicholson, A.G., Tsao, M.S., Beasley, M.B., et al. (2022) The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. Journal of Thoracic Oncology, 17, 362-387. [Google Scholar] [CrossRef] [PubMed]
[4] 张杰, 邵晋晨, 韩昱晨, 等. 细支气管腺瘤病理诊断若干问题[J]. 中华病理学杂志, 2020, 49(6): 529-533.
[5] 李么愁, 李英, 于香莉, 等. 细支气管腺瘤15例临床病理分析[J]. 临床与实验病理学杂志, 2021, 37(11): 1338-1342.
[6] Shao, J., Yin, J.C., Bao, H., et al. (2021) Morpho-logical, Immunohistochemical, and Genetic Analyses of Bronchiolar Adenoma and Its Putative Variants. The Journal of Pathology Clinical Research, 7, 287-300. [Google Scholar] [CrossRef] [PubMed]
[7] Yang, X., Hou, Y., Geng, J., et al. (2020) Ciliated Muconodular Papillary Tumors of the Lung: Distinct Molecular Features of an Insidious Tumor. Frontiers in Genetics, 11, Article ID: 579737. [Google Scholar] [CrossRef] [PubMed]
[8] Li, X., Wu, Y., Hui, D., et al. (2021) Multiple Bronchiolar Ade-nomas with Malignant Transformation and CCNE1 Mutation: A Case Report and Literature Review. Journal of Cardio-thoracic Surgery, 16, Article No. 307. [Google Scholar] [CrossRef] [PubMed]
[9] Han, X., Hao, J., Ding, S., et al. (2021) Bronchiolar Adenoma Transforming to Invasive Mucinous Adenocarcinoma: A Case Repot. OncoTargets and Therapy, 14, 2241-2246. [Google Scholar] [CrossRef
[10] Liu, X.L., Miao, C.F., Li, M., et al. (2023) Malignant Transformation of Pulmonary Bronchiolar Adenoma into Mucinous Adenocarcinoma: A Case Report. World Journal of Clinical Cases, 11, 233-241. [Google Scholar] [CrossRef] [PubMed]
[11] 王恩华. 细支气管腺瘤: 易与癌混淆的良性肿瘤[J]. 中华病理学杂志, 2019, 48(6): 425-432.
[12] Jones, R.T., Abedalthagafi, M.S., Brahmandam, M., et al. (2015) Cross-Reactivity of the BRAF VE1 Antibody with Epitopes in Axonemal Dyneins Leads to Staining of Cilia. Modern Pathology, 28, 596-606. [Google Scholar] [CrossRef] [PubMed]
[13] Sangani, R.G., Deepak, V., Ghio, A.J., et al. (2023) Peribronchi-olar Metaplasia: A Marker of Cigarette Smoke-Induced Small Airway Injury in a Rural Cohort. Clinical Pathology, 16. [Google Scholar] [CrossRef
[14] Wang, H., Lin, D.L. and Hu, Y.J. (2020) Solitary Peribronchi-olar Metaplasia and Bronchiolar Adenoma: Do They Represent an Equal Entity? General Thoracic and Cardiovascular Surgery, 68, 204-205. [Google Scholar] [CrossRef] [PubMed]